Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 10236
Country/Region: Zambia
Year: 2016
Main Partner: University Teaching Hospital - Zambia
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $7,844,967 Additional Pipeline Funding: $779,213

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $455,123
Care: Orphans and Vulnerable Children (HKID) $250,000
Care: TB/HIV (HVTB) $365,371
Care: Pediatric Care and Support (PDCS) $400,000
Laboratory Infrastructure (HLAB) $663,427
Strategic Information (HVSI) $19,031
Testing: HIV Testing and Counseling (HVCT) $272,424
Sexual Prevention: Other Sexual Prevention (HVOP) $913,427
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,250,000
Treatment: Adult Treatment (HTXS) $2,956,164
Treatment: Pediatric Treatment (PDTX) $300,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 300
GEND_GBV Age/Sex: <10 Male 2017 5
GEND_GBV Age/Sex: 10-14 Female 2017 685
GEND_GBV Age/Sex: 10-14 Male 2017 10
GEND_GBV Age/Sex: 15-19 Female 2017 1,000
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 600
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 2,000
GEND_GBV Number of people receiving post-GBV care 2017 2,000
GEND_GBV Sum of Age/Sex Disaggregates 2017 1,000
HTS_TST Age/sex: <1 2017 6,322
HTS_TST Age/sex: 1-9 2017 6,541
HTS_TST Age/sex: 10-14 Female 2017 976
HTS_TST Age/sex: 10-14 Male 2017 720
HTS_TST Age/sex: 15-19 Female 2017 671
HTS_TST Age/sex: 15-19 Male 2017 574
HTS_TST Age/sex: 20-24 Female 2017 2,007
HTS_TST Age/sex: 20-24 Male 2017 1,493
HTS_TST Age/sex: 25-49 Female 2017 13,947
HTS_TST Age/sex: 25-49 Male 2017 12,327
HTS_TST Age/sex: 50+ Female 2017 329
HTS_TST Age/sex: 50+ Male 2017 352
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 7,366
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 7,193
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 16,954
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 14,746
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 46,259
HTS_TST Service Delivery Point (Facility): Inpatient 2017 31,259
HTS_TST Service Delivery Point (Facility): PMTCT 2017 12,000
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,500
HTS_TST Service Delivery Point (Facility): VCT 2017 500
HTS_TST Sum of Age/Sex disaggregates 2017 33,396
HTS_TST Sum of Aggregated Age/Sex <15 2017 14,559
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 31,700
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 46,259
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 106
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 79
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 106
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 163
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 360
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 405
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 2,831
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 2,093
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 63
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 74
HTS_TST_POS Test Result by Age: Positive: <1 2017 287
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 692
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 608
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 556
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3,360
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,735
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,200
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 1,200
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 2,400
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support 1-9 Male 2017 60
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 1-9 2017 70
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2017 100
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2017 60
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2017 100
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2017 34
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2017 520
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2017 410
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2017 520
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2017 406
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Programs Female 1-9 2017 80
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Programs Male 1-9 2017 40
PMTCT_ART Already on ART at beginning of current pregnancy 2017 7,624
PMTCT_ART New on ART 2017 235
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,208
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 5,482
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 2,358
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 118
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 275
PMTCT_EID Sum of Infant Age disaggregates 2017 7,840
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 2,612
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 4,639
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 15,957
PMTCT_STAT By: Known positives at entry 2017 7,624
PMTCT_STAT By: Number of new positives identified 2017 235
PMTCT_STAT Number of new ANC and L&D clients 2017 35,477
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,208
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 235
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 1,255
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 6,134
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 13
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 80
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 142
PMTCT_STAT Sum of Positives Status disaggregates 2017 7,859
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 3,993
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 7,091
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 24,393
PP_PREV Aggregated Age/sex: <15 Female 2017 2,234
PP_PREV Aggregated Age/sex: <15 Male 2017 1,100
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 3,334
PP_PREV Total number of people in the target population 2017 3,334
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 150
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 225
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 150
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 225
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 750
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 750
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 350
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 350
TB_SCREENDX Screen Result: Screened Positive for TB 2017 350
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,888
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,882
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,752
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,753
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 9,275
TX_CURR Age/Sex: <1 2017 39
TX_CURR Age/Sex: <1-9 2017 237
TX_CURR Age/Sex: 10-14 Female 2017 145
TX_CURR Age/Sex: 10-14 Male 2017 143
TX_CURR Age/Sex: 15-19 Female 2017 450
TX_CURR Age/Sex: 15-19 Male 2017 450
TX_CURR Age/Sex: 20-24 Female 2017 850
TX_CURR Age/Sex: 20-24 Male 2017 850
TX_CURR Age/Sex: 25-49 Female 2017 886
TX_CURR Age/Sex: 25-49 Male 2017 891
TX_CURR Age/Sex: 50+ Female 2017 10
TX_CURR Age/Sex: 50+ Male 2017 10
TX_CURR Aggregated Age/Sex: <15 Female 2017 282
TX_CURR Aggregated Age/Sex: <15 Male 2017 282
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,196
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,201
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 4,961
TX_CURR Sum of age/sex disaggregates 2017 900
TX_CURR Sum of Aggregated Age/Sex <15 2017 564
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 4,397
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 4,961
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 123
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 123
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 748
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 748
TX_NEW By Age/Sex: <1 2017 20
TX_NEW By Age/Sex: 1-9 2017 122
TX_NEW By Age/Sex: 10-14 Female 2017 52
TX_NEW By Age/Sex: 10-14 Male 2017 52
TX_NEW By Age/Sex: 15-19 Female 2017 100
TX_NEW By Age/Sex: 15-19 Male 2017 100
TX_NEW By Age/Sex: 20-24 Female 2017 230
TX_NEW By Age/Sex: 20-24 Male 2017 230
TX_NEW By Age/Sex: 25-49 Female 2017 408
TX_NEW By Age/Sex: 25-49 Male 2017 408
TX_NEW By Age/Sex: 50+ Female 2017 10
TX_NEW By Age/Sex: 50+ Male 2017 10
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,742
TX_NEW Sum of Age/Sex disaggregates 2017 1,600
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,742
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,240
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,240
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 282
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 282
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 338
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 338
TX_PVLS Numerator: Indication: Routine 2017 1,240
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 282
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 282
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 338
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 338
TX_PVLS_den Denominator: Indication: Routine 2017 1,240
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 113
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 220
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 220
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 300
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 300
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 201
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 200
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 317
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 319
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 297
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 296
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 818
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 819
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,230
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,264
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 58
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 343
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 103
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 93
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 152
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 50
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 455
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 130
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,603
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,014
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 127
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 136
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 156
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,561
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,405